Division 4 PROCESS REQUIREMENTSF1
United Kingdom Repealed
- 4.1General
- 4.2Notified body quotations and pre-application activities
- 4.3Application review and contract
- 4.4Allocation of resources
- 4.5Conformity assessment activities
- 4.6Reporting
- 4.7Final review
- 4.8Decisions and Certifications
- 4.9Changes and modifications
- 4.10Surveillance activities and post-certification monitoring
- 4.11Re-certification
Annotations
Textual amendments
- F1
Regulation revoked (31.12.2020) by The Medical Devices Regulations 2002 (S.I. 2002/618), reg. 4O (with savings and transitional provisions for N.I. in reg. 3ZA) (as amended by S.I. 2019/791, regs. 1(1), 3(7) and by S.I. 2020/1478, regs. 1(3), Sch. 2 para. 2; and as amended (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 4, 32); 2020 c. 1, Sch. 5 para. 1(1))